Fragment-Based Hologram QSAR Studies on a Series of 2,4-Dioxopyrimidine-1-Carboxamides As Highly Potent Inhibitors of Acid Ceramidase

被引:0
|
作者
Yang, Xiang-Lin [1 ,2 ]
Zhou, Yuan [2 ]
Liu, Xin-Ling [2 ]
机构
[1] Hunan Univ Sci & Technol, Coll Chem & Chem Engn, Xiangtan 411201, Hunan, Peoples R China
[2] Hunan Inst Engn, Coll Chem & Chem Engn, Xiangtan 411104, Hunan, Peoples R China
来源
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH | 2016年 / 15卷
关键词
Acid ceramidase; Drug design; Inhibitors; Hologram QSAR; SPHINGOLIPID METABOLISM; ANALOGS; DISCOVERY; APOPTOSIS; PROSTATE; MAPP; B13;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A series of structurally related 2,4-dioxopyrimidine-1-carboxamide derivatives as highly potent inhibitors against acid ceramidase were subjected to hologram quantitative structure-activity relationship (HQSAR) analysis. A training set containing 24 compounds served to establish the HQSAR model. The best HQSAR model was generated using atoms, bond, connectivity, donor and acceptor as fragment distinction and 3-6 as fragment size with six components showing cross-validated q(2) value of 0.834 and conventional r(2) value of 0.965. The model was then employed to predict the potency of test set compounds that were excluded in the training set, and a good agreement between the experimental and predicted values was observed exhibiting the powerful predictable capability of this model (r(pred)(2) = 0.788). Atom contribution maps indicate that the electron-withdrawing effects at position 5 of the uracil ring, the preferential acyl substitution at N3 position and the substitution of eight-carbon alkyl chain length at N1 position predominantly contribute to the inhibitory activity. Based upon these key structural features derived from atom contribution maps, we have designed novel inhibitors of acid ceramidase possessing better inhibitory activity.
引用
收藏
页码:139 / 148
页数:10
相关论文
共 29 条
  • [1] Atom based 3D-QSAR studies on 2,4-dioxopyrimidine-1-carboxamide analogs: Validation of experimental inhibitory potencies towards acid ceramidase
    Bhattacherjee, Debojit
    Bhabak, Krishna Pada
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2016, 83 : 8 - 18
  • [2] Fragment-Based Discovery of Potent and Selective DDR1/2 Inhibitors
    Murray, Christopher W.
    Berdini, Valerio
    Buck, Ildiko M.
    Carr, Maria E.
    Cleasby, Anne
    Coyle, Joseph E.
    Curry, Jayne E.
    Day, James E. H.
    Day, Phillip J.
    Hearn, Keisha
    Iqbal, Aman
    Lee, Lydia Y. W.
    Martins, Vanessa
    Mortenson, Paul N.
    Munck, Joanne M.
    Page, Lee W.
    Patel, Sahil
    Roomans, Susan
    Smith, Kirsten
    Tamanini, Emiliano
    Saxty, Gordon
    ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (07): : 798 - 803
  • [3] Fragment-Based QSAR and Structural Analysis of a Series of Hydroxyethylamine Derivatives as HIV-1 Protease Inhibitors
    Ferreira, Leonardo G.
    Andricopulo, Adriano D.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2015, 18 (05) : 464 - 475
  • [4] Structural and chemical basis for enhanced affinity to a series of mycobacterial thymidine monophosphate kinase inhibitors: fragment-based QSAR and QM/MM docking studies
    Bueno, Renata V.
    Toledo, Ney R.
    Neves, Bruno J.
    Braga, Rodolpho C.
    Andrade, Carolina H.
    JOURNAL OF MOLECULAR MODELING, 2013, 19 (01) : 179 - 192
  • [5] Structural and chemical basis for enhanced affinity to a series of mycobacterial thymidine monophosphate kinase inhibitors: fragment-based QSAR and QM/MM docking studies
    Renata V. Bueno
    Ney R. Toledo
    Bruno J. Neves
    Rodolpho C. Braga
    Carolina H. Andrade
    Journal of Molecular Modeling, 2013, 19 : 179 - 192
  • [6] Combining NMR and X-ray Crystallography in Fragment-Based Drug Discovery: Discovery of Highly Potent and Selective BACE-1 Inhibitors
    Wyss, Daniel F.
    Wang, Yu-Sen
    Eaton, Hugh L.
    Strickland, Corey
    Voigt, Johannes H.
    Zhu, Zhaoning
    Stamford, Andrew W.
    FRAGMENT-BASED DRUG DISCOVERY AND X-RAY CRYSTALLOGRAPHY, 2012, 317 : 83 - 114
  • [7] Discovery of potent 2-Indole-acylsulfonamide Mcl-1 inhibitors using structure guided fragment-based methods
    Shaw, Subrata
    Tarr, James Chris
    Pelz, Nicholas
    Bian, Zhiguo
    Belmar, Johannes
    Zhao, Bin
    Goodwin, Craig
    Arnold, Allison
    Sensintaffar, John
    Rossanese, Olivia
    Lee, Taekyu
    Olejniczak, Edward
    Fesik, Stephen
    CANCER RESEARCH, 2016, 76
  • [8] Pharmacophore elucidation and 3D-QSAR analysis of a new class of highly potent inhibitors of acid ceramidase based on maximum common substructure and field fit alignment methods
    Pirhadi, Somayeh
    Shiri, Fereshteh
    Ghasemi, Jahan B.
    JOURNAL OF THE IRANIAN CHEMICAL SOCIETY, 2014, 11 (05) : 1329 - 1336
  • [9] Pharmacophore elucidation and 3D-QSAR analysis of a new class of highly potent inhibitors of acid ceramidase based on maximum common substructure and field fit alignment methods
    Somayeh Pirhadi
    Fereshteh Shiri
    Jahan B. Ghasemi
    Journal of the Iranian Chemical Society, 2014, 11 : 1329 - 1336
  • [10] Fragment-based modification of 2,4-diarylaminopyrimidine derivatives as ALK and ROS1 dual inhibitors to overcome secondary mutants
    Zhu, Minglin
    Li, Wei
    Zhao, Tianming
    Chen, Yuxiang
    Li, Tong
    Wei, Shangfei
    Guo, Ming
    Zhai, Xin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (20)